Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 13,488	$ 7,255
General and administrative	4,151	3,764
Total operating expenses	17,639	11,019
Loss from operations	(17,639)	(11,019)
Other income (expense):
Interest income	1,120	109
Other expense	(1)
Total other income	1,119	109
Net loss	(16,520)	(10,910)
Comprehensive loss:
Net loss	(16,520)	(10,910)
Other comprehensive loss:
Unrealized gain (loss) on securities	265	(585)
Comprehensive loss	$ (16,255)	$ (11,495)
Net loss per share, basic	$ (0.67)	$ (0.45)
Net loss per share, diluted	$ (0.67)	$ (0.45)
Weighted-average shares of common stock outstanding, basic	24,777,847	24,410,393
Weighted-average shares of common stock outstanding, diluted	24,777,847	24,410,393